Table 3 |
||||||
|
Multiple linear regression of factors associated with BDI-21 |
||||||
| 95% Confidence interval |
||||||
|
|
||||||
| Factor |
Unstandardized coefficient |
Lower bound |
Upper bound |
Standardized coefficients |
p Value |
Tolerance |
|
|
||||||
| (Constant) |
4.990 |
3.559 |
6.420 |
0.001 |
||
| Seizure frequency > 1/month |
4.353 |
2.076 |
6.630 |
0.254 |
0.001 |
0.978 |
| Symptomatic focal epilepsy |
3.050 |
1.107 |
4.402 |
0.208 |
0.002 |
0.978 |
|
The base omitted factors are gender, SF < 1/year, SF > 1/year, CFE, IGE, AED1, AED2, AED 3, age and disease duration. | ||||||
Kimiskidis et al. Annals of General Psychiatry 2007 6:28 doi:10.1186/1744-859X-6-28 |
||||||
